Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 423 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR ¿Puede una biopsia hacer que mi cáncer se disemine? December 9, 2021 Taking Time for the Everyday Things in 2024 December 29, 2023 Treatment with Brigatinib Results in Radiographic Responses and Clinical Benefit in... July 4, 2024 High Sensitivity of Mismatch Repair–Deficient Locally Advanced Rectal Cancer to Single-Agent... June 8, 2022 Load more HOT NEWS Drug Combination May Target the Unique Metabolism of Leukemia Stem Cells No EFS Benefit From Adding Atezolizumab To 1-Year BCG Therapy In... Limited Efficacy of Nivolumab plus Ipilimumab in Adenoid Cystic Carcinomas, but... Efficacy of Sunitinib in Patients with Metastatic Phaeochromocytomas and Paragangliomas
